PRIME Subsidiaries Enter into Power Purchase Agreement with PEA for Solar Farm Project
Miti Stock – Prime Road Power Public Company Limited or PRIME, a leading company in the clean energy business, by Mr. Somprasong Panjalak, Chairman of the Board and Chief Executive Officer, said that the company on December 7, 2023, two subsidiaries of PRIME holds 99.99% of shares entered into a power purchase agreement (PPA) with […]
Handok’s Treatment Drug for Congenital Hyperinsulinism Granted Priority Medicines Status by European Medicines Agency
Handok, under the leadership of CEO Kim Young-jin, has achieved a major milestone in the field of medicine. The European Medicines Agency (EMA) has granted priority medicines (PRIME) status to the treatment drug ‘RZ358’ for congenital hyperinsulinism. This recognition is reserved for new drugs that show potential benefits to patients in areas of unmet medical […]
US Stock Market Weakens for Third Consecutive Day Amid Powell’s Remarks on Further Tightening
On October 21st, the three major indexes of the New York Stock Exchange closed weak for the third consecutive day. Investor sentiment was negatively impacted by Federal Reserve Chairman Jerome Powell’s remarks suggesting further tightening. During a House Financial Services Committee hearing, Chairman Powell stated that almost every member of the FOMC believes it is […]
[약업신문]Takeda Announces Follow-up Clinical Data for Zejula Ovarian Cancer Patients
Takeda Pharmaceutical said follow-up study data from the phase 3 PRIMA study confirmed the potential for long-term treatment effects of first-line maintenance therapy Zejula for BRCA-mutation and HRD-positive patients. The picture is a product image of Zejula. © Takeda Pharmaceutical Takeda Pharmaceutical Korea (CEO Moon Hee-seok) presented two posters at the 2023 American Society of […]
